The -765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: A meta-analysis

Tohoku Journal of Experimental Medicine

Volumn 222, Issue 1, 2010, Pages 15-21

  Cao, Hui ^a   Xu, Zhong ^b   Long, Hao ^a   Li, Xiao qing ^a   Li, Shao lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal neoplasm; COX2; Gene polymorphism; Meta analysis; Susceptibility

Indexed keywords

CYCLOOXYGENASE 2; CYTOSINE;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; COLORECTAL CARCINOMA; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ALLELES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77956211572     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.222.15     Document Type: Article

References (36)

1. Ahmed, F.E. (2006) Gene-gene, gene-environment & multiple interactions in colorectal cancer. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 24, 1-101.
2. Ahnen, D.J. (1998) Colon cancer prevention by NSAIDs: what is the mechanism of action? Eur. J. Surg. Suppl., 111-114.
3. Andersen, V., Ostergaard, M., Christensen, J., Overvad, K., Tjonneland, A. & Vogel, U. (2009) Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer, 9, 407.
4. Begg, C.B. & Mazumdar, M. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-1101.
5. Cancer fact sheets. (2009) World Health Organisation. [retrieved on Jun. 22, 2010] http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
6. Chan, A.T., Ogino, S. & Fuchs, C.S. (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med., 356, 2131-2142.
7. Cox, D.G., Pontes, C., Guino, E., Navarro, M., Osorio, A., Canzian, F. & Moreno, V. (2004) Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br. J. Cancer, 91, 339-343.
8. Cross, J.T., Poole, E.M. & Ulrich, C.M. (2008) A review of genedrug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia. Pharmacogenomics, J., 8, 237-247.
9. Davis, J.N., McCabe, M.T., Hayward, S.W., Park, J.M. & Day, M.L. (2005) Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells. Cancer Res., 65, 3633-3642.
10. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Control. Clin. Trials, 7, 177-188.
11. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. & DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
12. Edwards, J., Mukherjee, R., Munro, A.F., Wells, A.C., Almushatat, A. & Bartlett, J.M. (2004) HER2 and COX2 expression in human prostate cancer. Eur. J. Cancer, 40, 50-55.
13. Egger, M., Davey, Smith, G., Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
14. Fernandez, E., Gallus, S., La Vecchia, C., Talamini, R., Negri, E. & Franceschi, S. (2004) Family history and environmental risk factors for colon cancer. Cancer Epidemiol. Biomarkers Prev., 13, 658-661.
15. Hamajima, N., Takezaki, T., Matsuo, K., Saito, T., Inoue, M., Hirai, T., Kato, T., Ozeki, J. & Tajima, K. (2001) Genotype Frequencies of Cyclooxygenease 2 (COX2) Rare Polymorphisms for Japanese with and without Colorectal Cancer. Asian Pac. J. Cancer Prev., 2, 57-62.
16. Hoff, J.H., te Morsche, R.H., Roelofs, H.M., van der Logt, E.M., Nagengast, F.M. & Peters, W.H. (2009) COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk. World J. Gastroenterol., 15, 4561-4565.
17. Iglesias, D., Nejda, N., Azcoita, M.M., Schwartz, S. Jr., Gonzalez-Aguilera, J.J. & Fernandez-Peralta, A.M. (2009) Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer. Cancer Causes Control, 20, 1421-1429.
18. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. & Thun, M.J. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
19. Kampman, E., Slattery, M.L., Bigler, J., Leppert, M., Samowitz, W., Caan, B.J. & Potter, J.D. (1999) Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol. Biomarkers Prev., 8, 15-24.
20. Koh, W.P., Yuan, J.M., van den Berg, D., Lee, H.P. & Yu, M.C. (2004) Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br. J. Cancer, 90, 1760-1764.
21. Kovesdi, I., Reichel, R. & Nevins, J.R. (1987) Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc. Natl. Acad. Sci. USA, 84, 2180-2184.
22. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. & Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
23. Mantel, N. & Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 22, 719-748.
24. Ota, S., Bamba, H., Kato, A., Kawamoto, C., Yoshida, Y. & Fujiwara, K. (2002) Review article: COX-2, prostanoids and colon cancer. Aliment. Pharmacol. Ther., 16, (Suppl 2)102- 106.
25. Papafili, A., Hill, M.R., Brull, D.J., McAnulty, R.J., Marshall, R.P., Humphries, S.E. & Laurent, G.J. (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler. Thromb. Vas.c Biol., 22, 1631-1636.
26. Pereira, C., Pimentel-Nunes, P., Brandao, C., Moreira-Dias, L., Medeiros, R. & Dinis-Ribeiro, M. (2010) COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention. Eur. J. Gastroenterol. Hepatol. 22, 607-613.
27. Rao, M., Yang, W., Seifalian, A.M. & Winslet, M.C. (2004) Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer. Int. J. Colorectal Dis., 19, 1-11.
28. Reddy, B.S., Tokumo, K., Kulkarni, N., Aligia, C. & Kelloff, G. (1992) Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis, 13, 1019-1023.
29. Singh, J., Hamid, R. & Reddy, B.S. (1997) Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res., 57, 3465-3470.
30. Szczeklik, W., Sanak, M. & Szczeklik, A. (2004) Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J. Allergy Clin. Immunol., 114, 248-253.
31. Tan, W., Wu, J., Zhang, X., Guo, Y., Liu, J., Sun, T., Zhang, B., Zhao, D., Yang, M., Yu, D. & Lin, D. (2007) Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis, 28, 1197-1201.
32. Thompson, C.L., Plummer, S.J., Merkulova, A., Cheng, I., Tucker, T.C., Casey, G. & Li, L. (2009) No association between cyclooxygenase- 2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J, Gastroenterol., 15, 2240-2244.
33. Thun, M.J., Namboodiri, M.M. & Heath, C.W. Jr. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596.
34. Witton, C.J., Hawe, S.J., Cooke, T.G. & Bartlett, J.M. (2004) Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology, 45, 47-54.
35. Xing, L.L., Wang, Z.N., Jiang, L., Zhang, Y., Xu, Y.Y., Li, J., Luo, Y. & Zhang, X. (2008) Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index. World J. Gastroenterol., 14, 1785-1789.
36. Xu, Q., Ji, Y.S. & Schmedtje, J.F. Jr. (2000) Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure. J. Biol. Chem., 275, 24583-24589.